Filters
Term Search
You can select from the dropdown list OR enter your own terms to refine the search.
Last Updated: 10/31/2025
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
Rare gliomas: standard treatment approaches and new target therapies.
Journal: Current opinion in neurology
Published: September 24, 2025
Phase 1b Study of Tovorafenib, Plozalizumab or Vedolizumab Plus Standard-of-Care Immune Checkpoint Inhibitors in Patients with Advanced Melanoma.
Journal: Journal of Cancer
Published: May 20, 2025
The Use of Minor Response, Volumetric Assessment and Growth Rate Kinetics as Endpoints in Grade 1-3 Glioma Clinical Trials: a RANO perspective.
Journal: Neuro-oncology
Published: May 20, 2025
Author Correction: The type II RAF inhibitor tovorafenib in relapsed/refractory pediatric low-grade glioma: the phase 2 FIREFLY-1 trial.
Journal: Nature medicine
Published: April 16, 2025
Properties of FDA-approved small molecule protein kinase inhibitors: A 2025 update.
Journal: Pharmacological research
Published: March 29, 2025
Taste Profile and Relative Bioavailability of Tovorafenib Powder for Oral Suspension and Food Effect of the Tovorafenib Tablet in Healthy Participants.
Journal: Clinical pharmacology in drug development
Published: January 23, 2025
Striped Hair Colour Change on Tovorafenib in an 18-Year-Old Boy With a Brainstem Low-Grade Glioma.
Journal: Pediatric blood & cancer
Published: January 10, 2025
Radiographic and visual response to the type II RAF inhibitor tovorafenib in children with relapsed/refractory optic pathway glioma in the FIREFLY-1 trial.
Journal: Neuro-oncology
Published: December 19, 2024
Combinatorial screen of targeted agents with the PI3K inhibitors inavolisib, alpelisib, duvelisib, and copanlisib in multi-cell type tumor spheroids.
Journal: SLAS discovery : advancing life sciences R & D
Published: November 30, 2024
FDA Approval Summary: Tovorafenib for Relapsed or Refractory BRAF-Altered Pediatric Low-Grade Glioma.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: October 17, 2024
Type II RAF inhibitor tovorafenib for the treatment of pediatric low-grade glioma.
Journal: Expert review of clinical pharmacology
Published: October 16, 2024
Last Updated: 10/31/2025